Join
Live feed
·
PRReleasevia Quantisnow
Genelux Corporation logo

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

ByQuantisnow·Wall Street's wire, on your screen.
GNLX· Genelux Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNLX (Genelux Corporation) and more on Quantisnow.